EWM
SCNI

Edge Wealth Management’s Scinai Immunotherapeutics SCNI Stock Holding History

Edge Wealth Management’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3
Closed -$10K – 443
2020
Q3 		$10K Buy
+3
New +$11.5K ﹤0.01% 321
2019
Q2 		– Sell
-100
Closed – – 628
2019
Q1 		$0 Buy
+100
New +$52K ﹤0.01% 596
2018
Q1 		– Sell
-100
Closed -$1K – 575
2017
Q4 		$1K Hold
100
– – ﹤0.01% 509
2017
Q3 		$2K Hold
100
– – ﹤0.01% 492
2017
Q2 		$2K Hold
100
– – ﹤0.01% 484
2017
Q1 		$2K Hold
100
– – ﹤0.01% 460
2016
Q4 		$1K Buy
+100
New +$36.3K ﹤0.01% 458

Other funds holding SCNI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Edge Wealth Management's SCNI Position: Q4 2020 in Review

Edge Wealth Management sold out of Scinai Immunotherapeutics (SCNI) in Q4 2020, closing a stake of 3 shares — an estimated $10K sold.

Edge Wealth Management first reported a position in SCNI in Q4 2016 and held it in 7 quarters. The position peaked at $10K in Q3 2020. 13 funds tracked by Wall St. Rank hold SCNI as of Q4 2020.

  • Edge Wealth Management reported no remaining Scinai Immunotherapeutics position as of Q4 2020 after selling out during the quarter.
  • Edge Wealth Management sold 3 Scinai Immunotherapeutics shares in Q4 2020, an estimated $10K.
  • Edge Wealth Management first reported a position in Scinai Immunotherapeutics in Q4 2016 and held it in 7 quarters.
  • Edge Wealth Management's Scinai Immunotherapeutics position peaked at $10K in Q3 2020.
  • 13 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q4 2020.

Based on Edge Wealth Management's 13F filing for Q4 2020, filed 19 Jan 2021.